ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 202 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2023. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $549,516 | +325057.4% | 151,800 | +188.7% | 0.00% | – |
| Q1 2024 | $169 | -39.4% | 52,583 | +2.7% | 0.00% | – |
| Q3 2023 | $279 | -87.7% | 51,200 | -84.9% | 0.00% | -100.0% |
| Q2 2023 | $2,271 | -34.7% | 338,500 | -14.1% | 0.00% | -40.0% |
| Q1 2023 | $3,479 | +9.5% | 394,000 | -5.2% | 0.01% | +25.0% |
| Q4 2022 | $3,177 | -99.9% | 415,800 | -9.2% | 0.00% | -20.0% |
| Q3 2022 | $3,260,000 | -17.2% | 457,800 | -5.9% | 0.01% | 0.0% |
| Q2 2022 | $3,936,000 | -37.8% | 486,500 | +6.8% | 0.01% | -28.6% |
| Q1 2022 | $6,324,000 | -2.0% | 455,600 | +184.4% | 0.01% | -12.5% |
| Q1 2021 | $6,450,000 | – | 160,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,687,665 | $5,417,405 | 5.10% |
| Rubric Capital Management LP | 10,500,000 | $33,705,000 | 1.00% |
| Triatomic Management LP | 98,555 | $316,362 | 0.59% |
| Pier Capital, LLC | 1,103,441 | $3,542,046 | 0.49% |
| Newtyn Management, LLC | 623,690 | $2,002,045 | 0.40% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $96,279,803 | 0.36% |
| Matrix Capital Management Company, LP | 11,572,590 | $37,148,014 | 0.34% |
| Tejara Capital Ltd | 269,014 | $863,535 | 0.32% |
| Aristotle Atlantic Partners, LLC | 2,992,563 | $9,606,127 | 0.31% |
| DDD Partners, LLC | 739,739 | $2,374,562 | 0.29% |